Firstly, if you are interested in OTC stocks like Chugai Pharmaceutica, you will be doing yourself a massive favor by joining the Trader HR chat room (the people there are experts at tricky stocks like this), so do that now – we also strongly recommend Microcap Millionaires where you can learn how to profit hugely off lesser known OTC stocks (what you find there is much more interesting than CHGCY, in our view). These recommendations are current as of 2019-10-18. Now onto the news and analysis.
REPORTING FOR 2019-10-18 | BUNDESPREMIERLEAGUE.COM: We have conducted a deep analysis of how Chugai Pharmaceutica (CHGCY) has been trading over the last 2 weeks and the past day especially. On its latest session, Chugai Pharmaceutica (CHGCY) opened at 154.16, reaching a high of 154.16 and a low of 154.16 before closing at a price of 154.16. There was a total volume of 1136.0.
VOLUME INDICATORS: We saw an accumulation-distribution index of 359.77669, an on-balance volume of 154.85, chaikin money flow of 0.32958 and a force index of 5.6475. There was an ease of movement rating of 0.01087, a volume-price trend of 16.00224 and a negative volume index of 1000.0.
VOLATILITY: We noted an average true range of 1.2756, bolinger bands of 154.8874, an upper bollinger band of 153.8126, lower bollinger band of 154.16, a bollinger high band indicator of 1.0, bollinger low band indicator of 1.0, a central keltner channel of 154.16, high band keltner channel of 154.16, low band keltner channel of 154.16, a high band keltner channel indicator of 1.0 and a low band keltner channel indicator of 1.0. There was a donchian channel high band of 154.16, a donchian channel low band of 154.16, a donchian channel high band indicator of nan, and a donchian channel low band indicator of 1.0.
TREND: We calculated a Moving Average Convergence Divergence (MACD) of 0.00853, a MACD signal of 0.00474, a MACD difference of 0.00379, a fast Exponential Moving Average (EMA) indicator of 154.16, a slow Exponential Moving Average (EMA) indicator of 154.16, an Average Directional Movement Index (ADX) of unknown, an ADX positive of 20.0, an ADX negative of 20.0, a positive Vortex Indicator (VI) of 1.0, a negative VI of 1.0, a trend vortex difference of 0.05596, a trix of 7.07226, a Mass Index (MI) of 2.44, a Commodity Channel Index (CCI) of 66.66667, a Detrended Price Oscillator (DPO) of -14.52992, a KST Oscillator (KST) of 104.0601 and a KST Oscillator (KST Signal) of 104.0601 (leaving a KST difference of 0.68037). We also found an Ichimoku rating of 154.16, an Ichimoku B rating of 154.16, a Ichimoku visual trend A of 142.32997, an Ichimoku visual trend B of 145.69352, an Aroon Indicator (AI) up of 4.0 and an AI indicator down of 4.0. That left a difference of 4.0.
MOMENTUM: We found a Relative Strength Index (RSI) of 50.0, a Money Flow Index (MFI) of 100.0, a True Strength Index (TSI) of 100.0, an ultimate oscillator of 100.0, a stochastic oscillator of 50.0, a stochastic oscillator signal of 50.0, a Williams %R rating of -50.0 and an awesome oscillator of -0.26583.
RETURNS: There was a daily return of 10.40601, a daily log return of 0.24619 and a cumulative return of 0.2465.
What the heck does all of this mean? If you are new to technical analysis, the above may be gibberish to you, and that’s OK (though we do advise learning these things). The bottom line is that AS OF 2019-10-18 (if you are reading this later, the analysis will be out of date), our analysis of technical indicators for Chugai Pharmaceutica (CHGCY) is telling us that this is potentially a buy. Please comment if you disagree with this conclusion or if you find any errors in the analysis above.
For a more complete analysis, run all of this through the BTMA software. Also, to stay up to date with what is happening on Chugai Pharmaceutica, we strongly advise Chugai Pharmaceutica investors to subscribe to MarketBeat.com’s daily email newsletter for updates, news and analyst ratings on Chugai Pharmaceutica and any other stocks you want – without this you are trading blind:
DISCLAIMER: We are not registered investment advisers and the above analysis should be taken at face value only. We strongly advise against buying or selling Chugai Pharmaceutica (CHGCY) based solely on our analysis above, and are not responsible for any losses that you may incur if you choose make any investment decisions based on the above.
I am the driving force behind BPL and a professional daytrader. I will be providing technical analysis of various stocks on BPL.
Latest posts by Anthony Rankin (see all)
- What We Found On Calif First National (CFNB) (2019-11-15) - November 15, 2019
- We Analyzed Mimedx Group Inc (MDXG) – Here Is What We Found (2019-11-15) - November 15, 2019
- Professionals Have Reviewed Internet Initiative Japan Inc. (IIJIY)’s Latest Trading Session (2019-11-15) - November 15, 2019